Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis

Stroke

Volumn 44, Issue 5, 2013, Pages 1220-1225

  Markus, Hugh S ^a   Mäkelä, Kari Matti ^b   Bevan, Steve ^a   Raitoharju, Emma ^b   Oksala, Niku ^b   Bis, Joshua C ^c   O'Donnell, Chris ^d   Hainsworth, Atticus ^a   Lehtimäki, Terho ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

Author keywords

atherosclerosis; carotid stenosis; expression experiments; genetics; intima media thickness

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; MESSENGER RNA; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CELL NUCLEUS; CYTOPLASM; ENDOTHELIUM CELL; FEMORAL ARTERY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; AORTA; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTONE DEACETYLASES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; RISK FACTORS; STROKE;

EID: 84876830806     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000217     Document Type: Article

References (21)

1. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M et al. Genome-wide association study identifes a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet. 2012;44:328-33.
2. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009;10:32-42.
3. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, Olson EN. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 2002;110:479-488.
4. Langley B, Brochier C, Rivieccio M.A. Targeting histone deacetylases as a multifaceted approach to treat the diverse outcomes of stroke. Stroke. 2009;40:2899-2905.
5. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467.
6. Levula M, Oksala N, Airla N, Zeitlin R, Salenius JP, Järvinen O, et al. Genes involved in systemic and arterial bed dependent atherosclerosis- Tampere Vascular study. PLoS ONE. 2012;7:e33787.
7. Bis JC, Kavousi M, Franceschini N, Isaacs A, Abecasis GR, Schminke U, et al; CARDIoGRAM Consortium. Meta-analysis of genome-wide association studies from the CHARGE consortium identifes common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011;43:940-947.
8. Willer CJ, Li Y, Abecasis GR. METAL: fast and effcient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190-2191.
9. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell, JC, Cheng Y, et al. Genome-wide associations with ischaemic stroke and its subtypes-the METASTROKE collaboration. Lancet Neurol. 2012;11:951-962
10. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A defnition of advanced types of atherosclerotic lesions and a histological classifcation of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995;15:1512-1531.
11. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, et al. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratifcation and role in tumor cell growth. Clin Cancer Res. 2010;16:3240-3252.
12. Klinz FJ, Korkmaz Y, Bloch W, Raab WH, Addicks K. Histone deacet-ylases 2 and 9 are coexpressed and nuclear localized in human molar odontoblasts in vivo. Histochem Cell Biol. 2012;137:697-702
13. The CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL et al. Large-scale association analysis identifes new risk loci for coronary artery disease. Nat Genet. 2013;45:25-33.
14. Sitzer M, Puac D, Buehler A, Steckel DA, von Kegler S, Markus HS, et al. Internal carotid artery angle of origin: a novel risk factor for early carotid atherosclerosis. Stroke. 2003;34:950-955.
15. Mathiesen EB, Johnsen SH. Ultrasonographic measurements of sub-clinical carotid atherosclerosis in prediction of ischemic stroke. ActaNeurolScand Suppl. 2009;189:68-72.
16. Yang XJ, Seto E. Lysine acetylation: codifed crosstalk with other post-translational modifcations. Mol Cell. 2008;31:449-461.
17. McKinsey TA. Targeting infammation in heart failure with histone deacetylase inhibitors. Mol Med. 2011;17:434-441.
18. McKinsey TA, Zhang CL, Olson EN. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci. 2002;27:40-47.
19. Okamoto H, Fujioka Y, Takahashi A, Takahashi T, Taniguchi T, Ishikawa Y, et al. Trichostatin A, an inhibitor of histone deacetylase, inhibits smooth muscle cell proliferation via induction of p21(WAF1). J Atheroscler Thromb. 2006;13:183-191.
20. Bowes AJ, Khan MI, Shi Y, Robertson L, Werstuck GH. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-defcient mice: evidence in support of a role for endoplasmic reticulum stress and glyco-gen synthase kinase-3 in lesion development and hepatic steatosis. Am J Pathol. 2009;174:330-342.
21. Olesen JB, Abildstrøm SZ, Erdal J, Gislason GH, Weeke P, Andersson C, et al. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2011;20:964-971.